Project Overview

P_ERP016649

Effects_of_Propidium_Monoazide_(PMA)_Treatment_on_Mycobiome_and_Bacteriome_Analysis_of_Cystic_Fibrosis_Airways_during_Exacerbation

Visibility: Public
Publication: Effects_of_Propidium_Monoazide_(PMA)_Treatment_on_Mycobiome_and_Bacteriome_Analysis_of_Cystic_Fibrosis_Airways_during_Exacerbation Link
 Journal: PLoS_One
Source: NA
Sample Number: 36

Samples in this project
  

SampleID Type Habitat Year Sequence type MNS1 MAS2
S_ERP016649.ERR1551892 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551893 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551894 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551898 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551901 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551903 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551904 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551906 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551908 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551909 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551911 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551913 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551914 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551916 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551918 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551919 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551921 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551929 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551895 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551896 Other_humanbodysite Lung NA 16S_V3-V5 - -

1MNS (Microbiome Novelty Score): < 0.12: Non-novel; 0.12-0.2: Novel; > 0.2: Very novel; -: NA for samples before 2010

2MAS (Microbiome Attention Score): < 10: Low-attention; ≥ 10: High-attention; -: NA for samples before 2010